Day: November 25, 2025

Paris, 25 November 2025Capitalised terms used herein shall have the meaning specified for such terms in the Caisse Française de Financement Local base prospectus to the €75,000,000,000 Euro Medium Term Note Programme dated 10 June 2025 (the “Base Prospectus”).Caisse Française de Financement Local has decided to issue on 27 November 2025 – Euro 200,000,000 Fixed Rate Obligations Foncières due 17 May 2039 to be assimilated upon listing and form a single series with the existing Euro 500,000,000 Fixed Rate Obligations Foncières due 17 May 2039 issued on 17 May 2024, the existing Euro 250,000,000 Fixed Rate Obligations Foncières due 17 May 2039 issued on 22 May 2024, the existing Euro 150,000,000 Fixed Rate Obligations Foncières due 17 May 2039 issued on 13 November 2025 and the existing Euro 150,000,000 Fixed Rate Obligations Foncières due...

Schindellegi, Switzerland – 25 November 2025 Trifork Group AGCompany announcement no. 55/2025Financial Calendar 2026 Trifork today publishes its financial calendar for 2026.Q4 & Annual Report 2025 27 February 2026Annual General Meeting 2026 17 April 2026Q1 Report 2026 5 May 2026Q2 & Half-Year Report 2026 17 August 2026Q3 Report 2026 30 October 2026Financial reports are expected to be released around 07:00 CET on the specified dates. Investor & Media contactFrederik SvanholmGroup Investment Directorfrsv@trifork.com+41 79 357 7317 About Trifork GroupTrifork (Nasdaq Copenhagen: TRIFOR) is a pioneering global technology company, empowering enterprise and public sector customers with innovative digital products and solutions. With 1,197 employees across 16 countries, Trifork specializes in designing, building,...

American Rebel Holdings, Inc.Nashville Kroger 502 Retail ExpansionPlacement of 16oz American Rebel Light Beer cans in Kroger Store #502 advances the Company’s distribution-first growth plan in its home market, bringing America’s fastest growing patriotic, all natural low calorie light beer to another high profile Tennessee location Nashville, TN, Nov. 25, 2025 (GLOBE NEWSWIRE) — American Rebel Holdings, Inc. (NASDAQ: AREB), maker of American Rebel Light Beer (www.americanrebelbeer.com)—America’s Patriotic, God-fearing, Constitution-loving, National Anthem-singing, Stand Your Ground Beer—today announced that its 16oz American Rebel Light Beer cans are now available at Kroger Store #502 in downtown Nashville, Tennessee. The placement follows the November 12, 2025, reopening of Kroger’s flagship Nashville store at 800 Monroe...

Seven posters to be presented, including new X-TOLE OLE data supporting the ability to attain and regain extended periods of seizure freedom with long-term use of azetukalner Data will also highlight the impact of depression and burden of titration on patients with epilepsy, as well as new pre-clinical data from the Company’s NaV1.1 program in Dravet syndromeVANCOUVER, British Columbia and BOSTON, MA, Nov. 25, 2025 (GLOBE NEWSWIRE) — Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development and commercialization of life-changing therapeutics for patients in need, today announced multiple presentations at the upcoming American Epilepsy Society Annual Meeting (AES 2025), taking place December 5-9, 2025 at the Georgia World Congress Center in Atlanta,...

Zcash’s Dramatic Surge Over the Past 90 Days Underscores Rising Demand for Privacy-Enabled, Institution-Ready Digital Assets; Supports Reliance’s Focused Digital Asset Treasury Strategy LAKEWOOD, NJ, Nov. 25, 2025 (GLOBE NEWSWIRE) — Reliance Global Group, Inc. (Nasdaq: RELI) (“Reliance”, “we” or the “Company”) today announced that it has completed a strategic realignment of its Digital Asset Treasury (“DAT”), by consolidating its digital asset position into Zcash (ZEC). The Company has fully exited its prior holdings and reallocated the proceeds into Zcash, a leading privacy-preserving cryptocurrency built on Bitcoin’s foundational architecture. This decision follows a comprehensive strategic review in which the Company along with Blake Janover, the Chaiman of the Crypto Advisory Board determined, after an in-depth assessment,...

Company to advance care through broader access to breadth of skin substitutes across four unique technology platformsTissue TechnologiesIntegra dermal regenerative templates, decellularized dermal scaffolds and amniotic tissue membranes are included in the ruling.PRINCETON, N.J., Nov. 25, 2025 (GLOBE NEWSWIRE) — Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, commends the Centers for Medicare & Medicaid Services (CMS) on its Calendar Year 2026 Medicare Physician Fee Schedule and Outpatient Prospective Payment System rules. All Integra dermal regenerative templates, decellularized dermal scaffolds and amniotic tissue membranes, which are classified as skin substitutes by CMS, are included in the ruling. These products – Integra® matrices, PriMatrix®, Cytal® and...

Social Following for Frazier Tops 200K, Life After the Show is the 19th Podcast Added to PodcastOne’s Network Roster This Year for 211 Total Podcasts LOS ANGELES, Nov. 25, 2025 (GLOBE NEWSWIRE) — PodcastOne (Nasdaq: PODC), a leading publisher and podcast sales network, announced today that it has entered into a multi-year agreement with former New York Yankees outfielder Clint Frazier for the exclusive distribution rights to Frazier’s Life After the Show podcast. Life After the Show episodes drop weekly and feature Frazier’s takes on current baseball issues, guest interviews with former teammates and insiders, and his own journey navigating life after the majors. This podcast pulls back the curtain on the game like only a pro can. From inside stories from his time with the New York Yankees to unfiltered takes on the latest in sports,...

Company Expands Dealer Offering with New Heavy-Duty Platform as COR and SOLIS Prepare for Initial Orders Opening November 28 West Seneca, New York, Nov. 25, 2025 (GLOBE NEWSWIRE) — Worksport Ltd. (NASDAQ: WKSP) (“Worksport” or the “Company”), a U.S.-based innovator in advanced manufacturing, clean energy technologies and automotive accessories, serving both consumer and reseller markets, today announced that its newly released HD3 heavy-duty tonneau cover is now officially selling across the Company’s growing business-to-business (B2B) dealer network. Production of the HD3 began in mid-October, following the Company’s earlier announcement confirming that manufacturing had commenced. Introducing a Purpose-Built, Professional-Grade Cover for Dealers The HD3 platform, priced with a minimum advertised price (MAP) starting at $869,...

LOS ANGELES, Nov. 25, 2025 (GLOBE NEWSWIRE) — BlackLine, Inc. (Nasdaq: BL) (“BlackLine” or the “Company”) today issued the following statement: The Company and members of the Board of Directors actively meet with company stockholders on a regular basis. More recently, these meetings have included Engaged Capital with whom management and independent directors have met seven times in the past 12 months, including times when Engaged was and was not an investor in the Company. The Company remains open to constructive conversation with all stockholders. About BlackLineBlackLine (Nasdaq: BL), the future-ready platform for the Office of the CFO, drives digital finance transformation by empowering organizations with accurate, efficient, and intelligent financial operations. Built on the Studio360 platform, BlackLine unifies data, streamlines...

BOSTON, Nov. 25, 2025 (GLOBE NEWSWIRE) — Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies, today announced that its Phase 2 clinical trial evaluating intranasal foralumab in patients with amyotrophic lateral sclerosis (ALS) has been accepted for inclusion in the ALS MyMatch Program at the Sean M. Healey & AMG Center for ALS at Mass General Brigham. The study, supported by a grant from the ALS Association, will be led by Principal Investigators Suma Babu, MBBS, MPH, and James Berry, MD, MPH, at Mass General Brigham. The trial will enroll at multiple rapid-enrolling U.S. centers within the Network of Excellence for ALS (NEALS) Consortium. Successful investigational products from the Healey ALS MyMatch program may advance to future...